Quinidine: an "endangered species" drug appropriate for management of electrical storm in brugada syndrome

Stelios Paraskevaidis; Efstratios K Theofilogiannakos; Vasileios Kamperidis; Yiannis S Chatzizisis; Konstantinos Tsilonis; Vassilios P Vassilikos; George Dakos; George Stavropoulos; Antonios Ziakas; Stavros Hadjimiltiades; Ioannis H Styliadis

doi:10.1016/s0972-6292(16)30670-2

Quinidine: an "endangered species" drug appropriate for management of electrical storm in brugada syndrome

Indian Pacing Electrophysiol J. 2013 Sep 1;13(5):178-80. doi: 10.1016/s0972-6292(16)30670-2. eCollection 2013.

Authors

Stelios Paraskevaidis¹, Efstratios K Theofilogiannakos, Vasileios Kamperidis, Yiannis S Chatzizisis, Konstantinos Tsilonis, Vassilios P Vassilikos, George Dakos, George Stavropoulos, Antonios Ziakas, Stavros Hadjimiltiades, Ioannis H Styliadis

Affiliation

¹ 1st Cardiology Department, AHEPA University Hospital, Aristotle University Medical School, Thessaloniki, Greece.

Abstract

Brugada syndrome is an inherited channelopathy associated with an increased risk of syncope and sudden cardiac death. In rare cases it can be manifested with electrical storm. We report two cases of Brugada syndrome that presented with electrical storm and were treated successfully with oral quinidine, an "endangered species" drug.

Keywords: Brugada syndrome; electrical storm; quinidine.